Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleA groundbreaking study, spearheaded by the University of Edinburgh, has identified a unique hormonal signature in individuals with endometriosis. Researchers observed distinct variations in androgens, often referred to as 'male' hormones, including high levels of 11-ketotestosterone, among those affected by the condition. This significant finding could lead to a simple, non-invasive diagnostic blood test, potentially reducing the current average nine-year diagnosis time for endometriosis in the UK. The study successfully identified over 95 per cent of endometriosis patients in the trial, challenging the traditional view of the condition as solely oestrogen-driven. The team is seeking industry partners to develop the diagnostic test and explore new therapeutic targets based on these insights, which could revolutionise treatment. In fullEndometriosis ‘breakthrough’ could revolutionise treatment of chronic conditionMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Hormone discovery could pave way for faster endometriosis diagnosis
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleA groundbreaking study, spearheaded by the University of Edinburgh, has identified a unique hormonal signature in individuals with endometriosis. Researchers observed distinct variations in androgens, often referred to as 'male' hormones, including high levels of 11-ketotestosterone, among those affected by the condition. This significant finding could lead to a simple, non-invasive diagnostic blood test, potentially reducing the current average nine-year diagnosis time for endometriosis in the UK. The study successfully identified over 95 per cent of endometriosis patients in the trial, challenging the traditional view of the condition as solely oestrogen-driven. The team is seeking industry partners to develop the diagnostic test and explore new therapeutic targets based on these insights, which could revolutionise treatment. In fullEndometriosis ‘breakthrough’ could revolutionise treatment of chronic conditionMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
